Annual Reports

 
Quarterly Reports

  • 10-Q (May 3, 2013)
  • 10-Q (Nov 5, 2012)
  • 10-Q (Aug 6, 2012)
  • 10-Q (May 8, 2012)
  • 10-Q (Nov 9, 2011)
  • 10-Q (Sep 9, 2011)

 
8-K

 
Other

SanDisk 10-Q 2009
form_10q.htm




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q

þ
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
     
For the quarterly period endedMarch 29, 2009
 
OR
     
¨
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
     
For the transition period from ________________ to ________________

Commission file number:  000-26734
 
 
SANDISK CORPORATION
(Exact name of registrant as specified in its charter)

Delaware
 
77-0191793
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
 
Identification No.)
     
601 McCarthy Blvd.
Milpitas, California
 
95035
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code
(408) 801-1000

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes þ
No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes ¨
No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer þ
Accelerated filer ¨
Non accelerated filer ¨
Smaller reporting company ¨
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨
No þ

Number of shares outstanding of the issuer’s common stock $0.001 par value, as of March 29, 2009: 226,855,067.




 

 

Index

   
Page No.
PART I. FINANCIAL INFORMATION
Item 1.
Condensed Consolidated Financial Statements:
 
 
3
 
4
 
5
 
6
 
7
Item 2.
45
Item 3.
55
Item 4.
56
PART II. OTHER INFORMATION
Item 1.
57
Item 1A.
57
Item 2.
75
Item 3.
75
Item 4.
75
Item 5.
75
Item 6.
75
 
76
 
77



PART I. FINANCIAL INFORMATION

Condensed Consolidated Financial Statements

SANDISK CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)

   
March 29, 2009
   
December 28, 2008*
 
   
(In thousands)
 
ASSETS
           
Current assets
           
Cash and cash equivalents
  $ 1,090,079     $ 962,061  
Short-term investments
    395,088       477,296  
Accounts receivable from product revenues, net
    109,095       122,092  
Inventory
    552,170       598,251  
Deferred taxes
    17,123       84,023  
Other current assets
    224,071       469,961  
Total current assets
    2,387,626       2,713,684  
Long-term investments
    897,427       1,097,302  
Property and equipment, net
    373,147       396,987  
Notes receivable and investments in flash ventures with Toshiba
    1,467,612       1,602,291  
Deferred taxes
    46,019       15,188  
Intangible assets, net
    58,721       63,182  
Other non-current assets
    37,248       43,506  
Total assets
  $ 5,267,800     $ 5,932,140  
                 
LIABILITIES
               
Current liabilities
               
Accounts payable trade
  $ 128,524     $ 240,985  
Accounts payable to related parties
    299,851       370,006  
Convertible short-term debt
    75,000        
Other current accrued liabilities
    307,526       502,443  
Deferred income on shipments to distributors and retailers and deferred revenue
    178,012       149,575  
Total current liabilities
    988,913       1,263,009  
Convertible long-term debt
    892,314       954,094  
Non-current liabilities
    209,481       274,316  
Total liabilities
    2,090,708       2,491,419  
                 
Commitments and contingencies (see Note 12)
               
                 
EQUITY
               
Stockholders’ equity
               
Preferred stock
           
Common stock
    227       226  
Capital in excess of par value
    4,174,216       4,154,166  
Accumulated deficit
    (1,110,794 )     (902,799 )
Accumulated other comprehensive income
    113,786       188,977  
Total stockholders’ equity
    3,177,435       3,440,570  
Non-controlling interests
    (343 )     151  
Total equity
    3,177,092       3,440,721  
Total liabilities and equity
  $ 5,267,800     $ 5,932,140  
_________________
*
As adjusted for the adoption of new accounting standards.  See Note 1.

The accompanying notes are an integral part of these condensed consolidated financial statements.


SANDISK CORPORATION
(Unaudited)
 

 
   
Three months ended
 
   
March 29, 2009
   
March 30, 2008*
 
   
(In thousands, except per share amounts)
 
Revenues
           
Product
  $ 588,099     $ 724,051  
License and royalty
    71,372       125,916  
Total revenues
    659,471       849,967  
                 
Cost of product revenues
    657,478       576,604  
Amortization of acquisition-related intangible assets
    3,132       14,582  
Total cost of product revenues
    660,610       591,186  
Gross profit (loss)
    (1,139 )     258,781  
Operating expenses
               
Research and development
    86,936       111,434  
Sales and marketing
    37,878       80,156  
General and administrative
    38,325       57,804  
Amortization of acquisition-related intangible assets
    292       4,475  
Restructuring and other
    765        
Total operating expenses
    164,196       253,869  
Operating income (loss)
    (165,335 )     4,912  
Interest income
    19,368       25,756  
Interest (expense) and other income (expense), net
    (38,061 )     (11,871 )
Total other income (expense)
    (18,693 )     13,885  
Income (loss) before provision for income taxes
    (184,028 )     18,797  
Provision for income taxes
    23,967       7,837  
Net income (loss)
  $ (207,995 )   $ 10,960  
                 
Net income (loss) per share:
               
Basic
  $ (0.92 )   $ 0.05  
Diluted
  $ (0.92 )   $ 0.05  
Shares used in computing net income (loss) per share:
               
Basic
    226,529       224,518  
Diluted
    226,529       229,480  
_________________
*
As adjusted for the adoption of new accounting standards.  See Note 1.


The accompanying notes are an integral part of these condensed consolidated financial statements.


CONDENSED CONSOLIDATED> STATEMENT OF EQUITY
(Unaudited)
 
 

   
Stockholders’ Equity
             
   
Common Stock Shares
   
Common Stock
Par Value
   
Capital in Excess of Par Value*
   
Accumulated
Deficit*
   
Accumulated Other Comprehensive
Income
   
Total*
   
Non-Controlling
Interests
   
Total Equity
 
   
(In thousands)
 
Balance at December 28, 2008
    226,128     $ 226     $ 4,154,166     $ (902,799 )   $ 188,977     $ 3,440,570     $ 151     $ 3,440,721  
Net loss
                      (207,995 )           (207,995 )     (494 )     (208,489 )
Unrealized income on available-for-sale investments
                            11,186       11,186             11,186  
Foreign currency translation
                            (58,303 )     (58,303 )           (58,303 )
Unrealized loss on hedging activities
                            (28,074 )     (28,074 )           (28,074 )
Comprehensive loss
                                            (283,186 )     (494 )     (283,680 )
Issuance of shares pursuant to equity plans
    129             153                   153             153  
Issuance of stock pursuant to employee stock purchase plan
    455       1       4,416                   4,417             4,417  
Issuance of restricted stock
    143                                            
Share-based compensation expense
                15,481                   15,481             15,481  
Balance at March 29, 2009
    226,855     $ 227     $ 4,174,216     $ (1,110,794 )   $ 113,786     $ 3,177,435     $ (343 )   $ 3,177,092  
_________________
 *
As adjusted for the adoption of new accounting standards.  See Note 1.


The accompanying notes are an integral part of these condensed consolidated financial statements.




SANDISK CORPORATION
(Unaudited)

   
Three months ended
 
   
March 29, 2009
   
March 30, 2008*
 
   
(In thousands)
 
Cash flows from operating activities:
           
Net income (loss)
  $ (207,995 )   $ 10,960  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
               
Deferred and other taxes
    8,922       (9,446 )
Depreciation
    39,125       41,210  
Amortization
    18,344       33,670  
Provision for doubtful accounts
    2,163       5,774  
Share-based compensation expense
    16,330       23,226  
Excess tax benefit from share-based compensation
          (794 )
Impairment, restructuring and other charges
    9,038       3,934  
Other non-cash charges
    (6,027 )     5,392  
Changes in operating assets and liabilities:
               
Accounts receivable from product revenues
    10,833       276,937  
Inventory
    40,309       (140,362 )
Other assets
    220,383       109,981  
Accounts payable trade
    (112,460 )     (53,014 )
Accounts payable to related parties
    (70,155 )     3,721  
Other liabilities
    (83,071 )     (92,556 )
Total adjustments
    93,734       207,673  
Net cash provided by (used in) operating activities
    (114,261 )     218,633  
                 
Cash flows from investing activities:
               
Purchases of short and long-term investments
    (168,938 )     (354,955 )
Proceeds from sales of short and long-term investments
    422,112       434,364  
Proceeds from maturities of short and long-term investments
    36,630       190,049  
Acquisition of property and equipment
    (16,497 )     (56,774 )
Distribution from FlashVision Ltd.
    12,713        
Notes receivable issuance, Flash Partners Ltd. and Flash Alliance Ltd.
    (326,350 )     (37,418 )
Notes receivable proceeds, Flash Partners Ltd. and Flash Alliance Ltd.
    277,070        
Purchased technology and other assets
    1,210       1,125  
Net cash provided by investing activities
    237,950       176,391  
                 
Cash flows from financing activities:
               
Repayment of debt financing
          (9,785 )
Proceeds from employee stock programs
    4,570       6,437  
Excess tax benefit from share-based compensation
          794  
Net cash provided by (used in) financing activities
    4,570       (2,554 )
                 
Effect of changes in foreign currency exchange rates on cash
    (241 )     (934 )
Net increase in cash and cash equivalents
    128,018       391,536  
Cash and cash equivalents at beginning of the period
    962,061       833,749  
Cash and cash equivalents at end of the period
  $ 1,090,079     $ 1,225,285  
_________________
 *
As adjusted for the adoption of new accounting standards.  See Note 1.

The accompanying notes are an integral part of these condensed consolidated financial statements.


(Unaudited)

1.  
Organization and Summary of Significant Accounting Policies

Organization

These interim Condensed Consolidated Financial Statements are unaudited but reflect, in the opinion of management, all adjustments, consisting of normal recurring adjustments and accruals, necessary to present fairly the financial position of SanDisk Corporation and its subsidiaries (the “Company”) as of March 29, 2009, the Condensed Consolidated Statements of Operations and the Condensed Consolidated Statements of Cash Flows for the three months ended March 29, 2009 and March 30, 2008, and the Condensed Consolidated Statement of Equity for the three months ended March 29, 2009.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been omitted in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”).  These Condensed Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s most recent Annual Report on Form 10-K/A.  Certain prior period amounts have been reclassified to conform to the current period presentation.  The results of operations for the three months ended March 29, 2009 are not necessarily indicative of the results to be expected for the entire fiscal year.

The Company’s fiscal year ends on the Sunday closest to December 31, and its fiscal quarters end on the Sunday closest to March 31, June 30, and September 30, respectively.  The first quarter of fiscal years 2009 and 2008 ended on March 29, 2009 and March 30, 2008, respectively.  Fiscal year 2009 ends on January 3, 2010 and fiscal year 2008 ended on December 28, 2008.


SFAS 160.  The Company adopted Statement of Financial Accounting Standards No. 160 (“SFAS 160”), Noncontrolling Interests in Consolidated Financial Statements, an amendment of ARB No. 51.  As a result of the adoption of SFAS 160, the Company has reclassified for all periods presented non-controlling interests, formerly called a minority interest, to a component of equity in the Condensed Consolidated Balance Sheets and the Condensed Consolidated Statement of Equity.  SFAS 160 applies prospectively, except for presentation and disclosure requirements, which are applied retrospectively.

FSP APB 14-1.  The Company adopted Financial Accounting Standards Board (“FASB”) Staff Position (“FSP”) No. APB 14-1 (“FSP APB 14-1”), Accounting for Convertible Debt Instruments That May Be Settled in Cash Upon Conversion (Including Partial Cash Settlement).  FSP APB 14-1 is effective for the Company’s $1.15 billion aggregate principal amount of 1% Senior Convertible Notes due 2013 (the “1% Notes due 2013”) and requires retrospective application for all periods presented.  FSP APB 14-1 requires the issuer of convertible debt instruments with cash settlement features to separately account for the liability and equity components of the instrument.

As a result of the adoption of FSP APB 14-1, the Company has separately accounted for the liability and equity components of its 1% Notes due 2013.  The Company calculated the value of the conversion component of the debt and recorded this value as a component of equity and a corresponding debt discount.  The debt discount, which is a reduction to the carrying value of the debt, will be amortized as additional non-cash interest expense over the term of the original note.  The retrospective application of this pronouncement affects years 2006 through 2013.  Income taxes have been recorded on the foregoing adjustments to the extent tax benefits were available.  See Note 2, “Financing Arrangements.”


- 7 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 

The following table reflects the results of the adoption of FSP APB 14-1 in the Company’s Condensed Consolidated Statement of Operations for the three months ended March 30, 2008 (in thousands, except for per share amounts):

   
As Reported
   
As Adjusted
 
Interest (expense) and other income (expense), net
  $ 126     $ (11,871 )
Provision for income taxes
    12,914       7,837  
Net income
    17,880       10,960  
Net income per share:
               
Basic
  $ 0.08     $ 0.05  
Diluted
  $ 0.08     $ 0.05  

The cumulative effect of the retrospective change in accounting principle of $23.9 million was applied to the opening balance of accumulated deficit at December 29, 2008.



Use of Estimates.> The preparation of Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and accompanying notes.  The estimates and judgments affect the reported amounts of assets, liabilities, revenues, expenses and related disclosure of contingent liabilities.  On an ongoing basis, the Company evaluates its estimates, including those related to customer programs and incentives, intellectual property claims, product returns, bad debts, inventories and related reserves, investments, income taxes, warranty obligations, restructuring, contingencies, share-based compensation and litigation.  The Company bases estimates on historical experience and on other assumptions that its management believes are reasonable under the circumstances.  These estimates form the basis for making judgments about the carrying value of assets and liabilities when those values are not readily apparent from other sources.  Actual results could materially differ from these estimates.

- 8 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 

Recent Accounting Pronouncements

In April 2009, the FASB issued the following three FASB Staff Positions (“FSP”) intended to provide additional application guidance and enhance disclosures regarding fair value measurements and impairments of securities.


FSP FAS 115-2 and FAS 124-2.  >FSP FAS 115-2 and FAS 124-2, Recognition and Presentation of Other-Than-Temporary Impairments, amends current other-than-temporary impairment guidance in GAAP for debt securities to make the guidance more operational and to improve the presentation and disclosure of other-than-temporary impairments on debt and equity securities in the financial statements.  This FSP does not amend existing recognition and measurement guidance related to other-than-temporary impairments of equity securities.  The provisions of FSP FAS 115-2 and FAS 124-2 are effective for the Company’s interim period ending on June 28, 2009.  Management is currently evaluating the effect that the provisions of FSP FAS 115-2 and FAS 124-2 may have on the Company’s Condensed Consolidated Financial Statements.

FSP FAS 157-4.>  FSP FAS 157-4, Determining Fair Value When the Volume and Level of Activity for the Asset or Liability Have Significantly Decreased and Identifying Transactions That Are Not Orderly, provides additional guidance for estimating fair value in accordance with Statement of Financial Accounting Standards No. 157, Fair Value Measurements, when the volume and level of activity for the asset or liability have decreased significantly.  FSP FAS 157-4 also provides guidance on identifying circumstances that indicate a transaction is not orderly.  The provisions of FSP FAS 157-4 are effective for the Company’s interim period ending on June 28, 2009.  Management is currently evaluating the effect that the provisions of FSP FAS 157-4 may have on the Company’s Condensed Consolidated Financial Statements.


- 9 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 


2.  
Financing Arrangements
 
The following table reflects the carrying value of the Company’s convertible debt as of March 29, 2009 and December 28, 2008 (in millions):

   
March 29, 2009
   
December 28, 2008
 
1% Notes due 2013
  $ 1,150.0     $ 1,150.0  
Less: Unamortized Interest Discount
    (257.7 )     (270.9 )
Net Carrying Amount of 1% Notes due 2013
    892.3       879.1  
1% Notes due 2035
    75.0       75.0  
Total convertible debt
    967.3       954.1  
Less: convertible short-term debt
    (75.0 )      
Convertible long-term debt
  $ 892.3     $ 954.1  


As discussed in Note 1, “Basis of Presentation — FSP APB 14-1,” the Company separately accounts for the liability and equity components of the 1% Notes due 2013.  The principal amount of the liability component ($753.5 million as of the date of issuance) was recognized at the present value of its cash flows using a discount rate of 7.4%, the Company’s borrowing rate at the date of the issuance for a similar debt instrument without the conversion feature.  The carrying value of the equity component was $241.9 million as of March 29, 2009 and December 28, 2008.

The following table presents the amount of interest cost recognized for the periods relating to both the contractual interest coupon and amortization of the discount on the liability component (in millions):

   
Three months ended
 
   
March 29, 2009
   
March 30, 2008
 
Contractual interest coupon
  $ 2.9     $ 2.9  
Amortization of interest discount
    13.2       12.3  
Total interest cost recognized
  $ 16.1     $ 15.2  

The remaining interest discount (equity component) of $257.7 million as of March 29, 2009 will be amortized over the remaining life of the 1% Notes due 2013 which is approximately 4.1 years.

Concurrent with the issuance of the 1% Notes due 2013, the Company sold warrants to acquire shares of its common stock at an exercise price of $95.03 per share.  As of March 29, 2009, the warrants had an expected life of approximately 4.4 years and expire in August 2013.  At expiration, the Company may, at its option, elect to settle the warrants on a net share basis.  As of March 29, 2009, the warrants had not been exercised and remain outstanding.  In addition, counterparties agreed to sell to the Company up to approximately 14.0 million shares of its common stock, which is the number of shares initially issuable upon conversion of the 1% Notes due 2013 in full, at a conversion price of $82.36 per share.  The convertible bond hedge transaction will be settled in net shares and will terminate upon the earlier of the maturity date of the 1% Notes due 2013 or the first day that none of the 1% Notes due 2013 remain outstanding due to conversion or otherwise.  Settlement of the convertible bond hedge in net shares on the expiration date would result in the Company receiving net shares equivalent to the number of shares issuable by it upon conversion of the 1% Notes due 2013.  As of March 29, 2009, the Company had not purchased any shares under this convertible bond hedge agreement.


- 10 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 


Holders of the notes have the right to require the Company to purchase all or a portion of their notes on March 15, 2010, March 15, 2015, March 15, 2020, March 15, 2025 and March 15, 2030.  The purchase price payable will be equal to 100% of the principal amount of the notes to be purchased, plus accrued and unpaid interest, if any, to but excluding the purchase date.  Due to the short-term nature of the conversion rights, the Company has reclassified the entire value of the 1% Notes due 2035 to Convertible Short-term Debt in the Condensed Consolidated Balance Sheet as of March 29, 2009.


- 11 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 

3.  
Investments and Fair Value Measurements

Fair Value Hierarchy. >The Statement of Financial Accounting Standards No. 157 (“SFAS 157”), Fair Value Measurements, establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).  A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

The Company’s financial assets are measured at fair value on a recurring basis.  Instruments that are classified within Level 1 of the fair value hierarchy generally include most money market securities, U.S. agency securities and equity investments.  Instruments that are classified within Level 2 of the fair value hierarchy generally include U.S. agency securities, commercial paper, U.S. corporate notes and bonds, and municipal obligations.

Financial assets and liabilities measured at fair value under SFAS 157 on a recurring basis as of March 29, 2009 were as follows (in thousands):

   
Total
   
Quoted Prices in Active Markets for Identical Assets
(Level 1)
   
Significant Other Observable Inputs
(Level 2)
   
Significant Unobservable Inputs
(Level 3)
 
Fixed income securities
  $ 1,606,270     $ 381,974     $ 1,224,296     $  
Equity securities
    47,060       47,060              
Derivative assets
    68,702             68,702        
Other
    1,222             1,222        
Total financial assets
  $ 1,723,254     $ 429,034     $ 1,294,220     $  
                                 
Derivative liabilities
  $ 8,292     $     $ 8,292     $  
Total financial liabilities
  $ 8,292     $     $ 8,292     $  

Financial assets and liabilities measured at fair value under SFAS 157 on a recurring basis as December 28, 2008 were as follows (in thousands):

   
Total
   
Quoted Prices in Active Markets for Identical Assets
(Level 1)
   
Significant Other Observable Inputs
(Level 2)
   
Significant Unobservable Inputs
(Level 3)
 
Fixed income securities
  $ 1,822,466     $ 317,081     $ 1,505,385     $  
Equity investments
    37,227       37,227              
Derivative assets
    105,133             105,133        
Other
    2,889             2,889        
Total financial assets
  $ 1,967,715     $ 354,308     $ 1,613,407     $  
                                 
Derivative liabilities
  $ 153,523     $     $ 153,523     $  
Total financial liabilities
  $ 153,523     $     $ 153,523     $  

On December 29, 2008, the Company adopted FSP SFAS 157-2, Effective Date of FASB Statement No. 157, which allows companies to delay the application of SFAS 157 until fiscal years beginning after November 15, 2008, to certain fair value measurements, primarily non-financial assets and liabilities.  The Company has reviewed its non-financial assets and liabilities and has concluded that there were no non-financial assets or liabilities which qualified under the provisions of FSP SFAS 157-2 as of March 29, 2009.

- 12 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 


Assets and liabilities measured at fair value under SFAS 157 on a recurring basis as of March 29, 2009, were presented on the Company’s Condensed Consolidated Balance Sheet as follows (in thousands):

   
Total
   
Quoted Prices in Active Markets for Identical Assets
(Level 1)
   
Significant Other Observable Inputs
(Level 2)
   
Significant Unobservable Inputs
(Level 3)
 
Cash equivalents (1)
  $ 382,976     $ 381,974     $ 1,002     $  
Short-term investments
    395,088       3,489       391,599        
Long-term investments
    897,427       43,571       853,856        
Other current assets and other non-current assets
    47,763             47,763        
Total assets
  $ 1,723,254     $ 429,034     $ 1,294,220     $  
                                 
Other current accrued liabilities
  $ 8,292     $     $ 8,292     $  
Total liabilities
  $ 8,292     $     $ 8,292     $  

 
(1)  
Cash equivalents exclude cash of $707.1 million included in Cash and Cash Equivalents of the Condensed Consolidated Balance Sheet as of March 29, 2009.

As of March 29, 2009, the Company did not elect the fair value option under Statement of Financial Accounting Standards No. 159 (“SFAS 159”), Establishing the Fair Value Option for Financial Assets and Liabilities, for any financial assets and liabilities that were not required to be measured at fair value.

Available-for-Sale Investments.  >Available-for-sale investments as of March 29, 2009 and December 28, 2008 were as follows (in thousands):

   
March 29, 2009
   
December 28, 2008
 
   
Book Value
   
Gross Unrealized Gain
   
Gross Unrealized Loss
   
Market Value
   
Book Value
   
Gross Unrealized Gain
   
Gross Unrealized Loss
   
Market Value
 
Fixed income securities:
                                               
U.S. agency securities
  $ 29,216     $ 109     $ (3 )   $ 29,322     $ 40,110     $ 476     $     $ 40,586  
U.S. corporate notes and bonds
    40,155       278       (127 )     40,306       56,916       267       (360 )     56,823  
Municipal notes and bonds
    1,130,204       24,583       (119 )     1,154,668       1,387,592       21,714       (1,330 )     1,407,976  
      1,199,575       24,970       (249 )     1,224,296       1,484,618       22,457       (1,690 )     1,505,385  
Equity investments
    70,226       1,427       (24,593 )     47,060       70,226             (32,999 )     37,227  
Total available-for-sale investments
  $ 1,269,801     $ 26,397     $ (24,842 )   $ 1,271,356     $ 1,554,844     $ 22,457     $ (34,689 )   $ 1,542,612  


- 13 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 


Securities that have been in an unrealized loss position, the fair value and gross unrealized losses on the available-for-sale investments aggregated by type of investment instrument, and the length of time that individual securities have been in a continuous unrealized loss position as of March 29, 2009 are summarized in the following table (in thousands).  Available-for-sale securities that were in an unrealized gain position have been excluded from the table and all unrealized losses have been in a continuous unrealized loss position for less than 12 months.

   
Unrealized Loss for Less than 12 Months
 
   
Market Value
   
Gross
Unrealized Loss
 
U.S. agency securities, U.S. corporate and municipal notes and bonds
  $ 66,931     $ (249 )
Equity investments
    43,571       (24,593 )
Total
  $ 110,502     $ (24,842 )

The gross unrealized loss related to publicly traded equity investments were due to changes in market prices.  The Company has cash flow hedges designated to substantially mitigate risk from these equity investments as of March 29, 2009, as discussed in Note 4, “Derivatives and Hedging Activities.”  The gross unrealized loss related to U.S. agency securities, U.S. corporate and municipal notes and bonds were primarily due to changes in interest rates.  Gross unrealized losses on all available-for-sale fixed income securities at March 29, 2009 are considered temporary in nature.  Factors considered in determining whether a loss is temporary include the length of time and extent to which fair value has been less than the cost basis, the financial condition and near-term prospects of the investee, and the Company’s intent and ability to hold an investment for a period of time sufficient to allow for any anticipated recovery in market value.

Gross realized gains and losses on sales of available-for-sale securities for the fiscal quarter ended March 29, 2009 totaled $5.8 million and ($0.6) million, respectively.

Fixed income securities by contractual maturity as of March 29, 2009 are shown below (in thousands).  Actual maturities may differ from contractual maturities because issuers of the securities may have the right to prepay obligations.

   
Cost
   
Estimated
Fair Value
 
Due in one year or less
  $ 389,092     $ 392,602  
Due after one year through five years
    810,483       831,694  
Total
  $ 1,199,575     $ 1,224,296  


- 14 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 


4.  
Derivatives and Hedging Activities

The Company uses derivative instruments primarily to manage exposures to foreign currency and equity security price risks.  The Company’s primary objective in holding derivatives is to reduce the volatility of earnings and cash flows associated with changes in foreign currency and equity security prices.  The program is not designated for trading or speculative purposes.  The Company’s derivatives expose the Company to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement.  The Company seeks to mitigate such risk by limiting its counterparties to major financial institutions and by spreading the risk across several major financial institutions.  In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored on an ongoing basis.

In accordance with Statement of Financial Accounting Standards No. 133 (“SFAS 133”), Accounting for Derivative Instruments and Hedging Activities, and Statement of Accounting Standards No. 161 (“SFAS 161”), Disclosures about Derivative Instruments and Hedging Activities, the Company recognizes derivative instruments as either assets or liabilities on the balance sheet at fair value and provides qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.  Changes in fair value (i.e., gains or losses) of the derivatives are recorded as Cost of Product Revenues or Other Income (Expense), or as accumulated Other Comprehensive Income (“OCI”).

Cash Flow Hedges.  >The Company uses a combination of forward contracts and options designated as cash flow hedges to hedge a portion of future forecasted purchases in Japanese yen.  The gain or loss on the effective portion of a cash flow hedge is initially reported as a component of accumulated OCI and subsequently reclassified into Cost of Product Revenues in the same period or periods in which the cost of product revenues is recognized, or reclassified into Other Income (Expense) if the hedged transaction becomes probable of not occurring.  Any gain or loss after a hedge is de-designated because it is no longer probable of occurring or related to an ineffective portion of a hedge, as well as any amount excluded from the Company’s hedge effectiveness, is recognized as other income (expense) immediately, and was a net loss of $1.0 million for the three months ended March 29, 2009.  As of March 29, 2009, the Company had forward contracts and options in place that hedged future purchases of approximately 16.5 billion Japanese yen, or approximately $169 million, based upon the exchange rate as of March 29, 2009, and the net unrealized gain on the effective portion of these cash flow hedges was $12.2 million.  The forward and option contracts cover future Japanese yen purchases expected to occur over the next twelve months.

The Company has an outstanding cash flow hedge designated to mitigate equity risk associated with certain available-for-sale investments in equity securities.  The gain or loss on the cash flow hedge is reported as a component of accumulated OCI and will be reclassified into Other Income (Expense) in the same period that the equity securities are sold.  The securities had a fair value of $43.6 million and $35.2 million as of March 29, 2009 and December 28, 2008, respectively.  The cash flow hedge designated to mitigate equity risk of these securities had a fair value of $22.2 million and $32.0 million as of March 29, 2009 and December 28, 2008, respectively.

Other Derivatives.  >Other derivatives not designated as hedging instruments under SFAS 133 consist primarily of forward contracts to minimize the risk associated with the foreign exchange effects of revaluing monetary assets and liabilities.  Monetary assets and liabilities denominated in foreign currencies and the associated outstanding forward contracts were marked-to-market at March 29, 2009 with realized and unrealized gains and losses included in Other Income (Expense).  As of March 29, 2009, the Company had foreign currency forward contracts in place hedging exposures in European euros, Israeli new shekels, Japanese yen and Taiwanese dollars.  Foreign currency forward contracts were outstanding to buy and (sell) U.S. dollar equivalent of approximately $262 million and ($1.6) billion in foreign currencies, respectively, based upon the exchange rates at March 29, 2009.

For the three months ended March 29, 2009, non-designated foreign currency forward contracts resulted in a gain of $100.1 million including forward-point income.  For the three months ended March 29, 2009, the revaluation of the foreign currency exposures hedged by these forward contracts resulted in a loss of $100.2 million.  All of the above noted gains and losses are included in Interest (Expense) and Other Income (Expense), net, in the Company’s Condensed Consolidated Statements of Operations.

- 15 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 

The amounts in the tables below include fair value adjustments related to the Company’s own credit risk and counterparty credit risk.

Fair Value of Derivative Contracts.  >Fair value of derivative contracts under SFAS 133 were as follows (in thousands):

   
Derivative Assets Reported in
   
 Derivative Liabilities Reported in
 
   
Other Current Assets
   
Long-term Investments
   
Other Current Accrued Liabilities
 
   
March 29,
 2009
   
December 28,
 2008
   
March 29,
 2009
   
December 28,
 2008
   
March 29,
 2009
   
December 28,
 2008
 
Foreign exchange contracts designated as cash flow hedges
  $ 12,922     $ 51,576     $     $     $ 757     $  
Equity market risk contract designated as cash flow hedge
                22,161       31,987              
Total derivatives designated as hedging instruments
    12,922       51,576       22,161       31,987       757        
Foreign exchange contracts not designated
    33,620       21,570                   7,535       153,523  
Total derivatives
  $ 46,542     $ 73,146     $ 22,161     $ 31,987     $ 8,292     $ 153,523  


Foreign Exchange Contracts Designated as Cash Flow Hedges.  >The effective portion of designated cash flow derivative contracts under SFAS 133 on the results of operations were as follows (in thousands):

   
Three months ended
 
   
Amount of Loss Recognized in OCI
   
Amount of Gain Reclassified from OCI to the Statement of Operations
 
   
March 29,
 2009
   
March 28,
 2008
   
March 29,
 2009
   
March 28,
 2008
 
Foreign exchange contracts designated as cash flow hedges
  $ (14,638 )   $     $ 3,610     $  
Equity market risk contract designated as cash flow hedge
    (9,826 )                  

Foreign exchange contracts designated as cash flow hedges relate primarily to wafer purchases and the associated gains (losses) are expected to be recorded in Cost of Product Revenues when reclassified out of accumulated OCI.  Gains (losses) from the equity market risk contract are expected to be recorded in Other Income (Expense) when reclassified out of accumulated OCI.

The Company expects to realize the accumulated OCI balance related to foreign exchange contracts within the next twelve months and realize the accumulated OCI balance related to the equity market risk contract in fiscal year 2011.

The ineffective portion and amount excluded from effectiveness testing on designated cash flow derivative contracts under SFAS 133 on the Company’s results of operations recognized in Other Income (Expense) were as follows (in thousands):

   
Three months ended
 
   
March 29, 2009
   
March 30, 2008
 
Foreign exchange contracts designated as cash flow hedges
  $ (997 )   $  
Equity market risk contract designated as cash flow hedge
           


   
Three months ended
 
   
March 29, 2009
   
March 30, 2008
 
Gain (loss) on foreign exchange contracts
  $ 101,125     $ (65,087 )

- 16 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 


5.  
Balance Sheet Information


   
March 29, 2009
   
December 28, 2008
 
Trade accounts receivable
  $ 413,549     $ 584,262  
Allowance for doubtful accounts
    (16,068 )     (13,881 )
Price protection, promotions and other activities
    (288,386 )     (448,289 )
Total accounts receivable from product revenues, net
  $ 109,095     $ 122,092  


   
March 29, 2009
   
December 28, 2008
 
Raw material
  $ 264,330     $ 309,436  
Work-in-process
    137,217       90,544  
Finished goods
    150,623       198,271  
Total inventory
  $ 552,170     $ 598,251  


   
March 29, 2009
   
December 28, 2008
 
Royalty and other receivables
  $ 34,119     $ 81,451  
Prepaid expenses
    16,828       20,321  
Prepaid income taxes and tax related receivables
    126,401       294,906  
Other current assets
    46,723       73,283  
Total other current assets
  $ 224,071     $ 469,961  


   
March 29, 2009
   
December 28, 2008
 
Notes receivable, Flash Partners Ltd.
  $ 634,913     $ 843,380  
Notes receivable, Flash Alliance Ltd.
    441,011       276,518  
Investment in FlashVision Ltd.
          63,965  
Investment in Flash Partners Ltd.
    189,357       202,530  
Investment in Flash Alliance Ltd.
    202,331       215,898  
Total notes receivable and investments in the flash ventures with Toshiba
  $ 1,467,612     $ 1,602,291  

In the first quarter of fiscal year 2009, the Company completed the wind-down of FlashVision Ltd. (“FlashVision”) and received cash distributions of $12.7 million, released $34.0 million of cumulative translation adjustments recorded in accumulated OCI and recorded an impairment charge of $7.9 million in Other Income (Expense) related to FlashVision.

See Note 12, “Commitments, Contingencies and Guarantees – FlashVision, Flash Partners and Flash Alliance,” regarding equity method investments in the three months ended March 29, 2009 and Note 13, “Related Parties,” for the Company’s maximum loss exposure related to these variable interest entities.


- 17 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 


   
March 29, 2009
   
December 28, 2008
 
Accrued payroll and related expenses
  $ 54,253     $ 54,516  
Accrued restructuring
    17,198       22,545  
Research and development liability, related party
    2,000       4,000  
Foreign currency forward contract payables
    8,292       153,523  
Flash Ventures adverse purchase commitments for under utilized capacity
(see Note 12)
    62,778       121,486  
Other accrued liabilities
    163,005       146,373  
Total other current accrued liabilities
  $ 307,526     $ 502,443  


   
March 29, 2009
   
December 28, 2008
 
Deferred tax liability
  $ 16,723     $ 87,688  
Income taxes payable
    154,264       145,432  
Accrued restructuring
    10,578       11,070  
Other non-current liabilities
    27,916       30,126  
Total non-current liabilities
  $ 209,481     $ 274,316  

As of March 29, 2009 and December 28, 2008, the total current accrued restructuring liability was primarily comprised of contract termination costs related to the 2008 Restructuring Plans and the current portion of excess lease obligations.  See Note 9, “Restructuring Plans.”  The non-current accrued restructuring balance and activity from the prior year end was primarily related to excess lease obligations and cash lease obligation payments, respectively.  The lease obligations extend through the end of the lease term in fiscal year 2016.


- 18 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 

6.  
Intangible Assets

Intangible asset balances are presented below (in thousands):

   
March 29, 2009
 
   
Gross Carrying Amount
   
Accumulated Amortization
   
Net Carrying Amount
 
Core technology
  $ 79,800     $ (35,924 )   $ 43,876  
Developed product technology
    11,400       (5,225 )     6,175  
Acquisition-related intangible assets
    91,200       (41,149 )     50,051  
Technology licenses and patents
    16,526       (7,856 )     8,670  
Total
  $ 107,726     $ (49,005 )   $ 58,721  

   
December 28, 2008
 
   
Gross Carrying Amount
   
Impairment
   
Accumulated Amortization
   
Net Carrying Amount
 
Core technology
  $ 315,301     $ (136,001 )   $ (132,407 )   $ 46,893  
Developed product technology
    12,900             (6,318 )     6,582  
Customer relationships
    80,100       (39,784 )     (40,316 )      
Acquisition-related intangible assets
    408,301       (175,785 )     (179,041 )     53,475  
Technology licenses and patents
    23,814             (14,107 )     9,707  
Total
  $ 432,115     $ (175,785 )   $ (193,148 )   $ 63,182  

The annual expected amortization expense of intangible assets that existed as of March 29, 2009, is presented below (in thousands):

   
Estimated Amortization Expenses
 
Fiscal year:
 
Acquisition-Related Intangible Assets
   
Technology Licenses and Patents
 
2009 (remaining nine months)
  $ 10,271     $ 3,414  
2010
    13,695       3,121  
2011
    13,034       1,268  
2012
    12,529       620  
2013
    522       245  
2014 and thereafter
          2  
Total
  $ 50,051     $ 8,670  

- 19 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 


7.  
Warranties

Liability for warranty expense is included in Other Current Accrued Liabilities and Non-current Liabilities in the accompanying Condensed Consolidated Balance Sheets and the activity was as follows (in thousands):

   
Three months ended
 
   
March 29, 2009
   
March 30, 2008
 
Balance, beginning of period
  $ 36,469     $ 18,662  
Additions
    4,913       11,155  
Usage
    (10,088 )     (16,124 )
Balance, end of period
  $ 31,294     $ 13,693  

The majority of the Company’s products have a warranty ranging from one to five years.  A provision for the estimated future cost related to warranty expense is recorded at the time of customer invoice.  The Company’s warranty liability is affected by customer and consumer returns, product failures, number of units sold, and repair or replacement costs incurred.  Should actual product failure rates, or repair or replacement costs differ from the Company’s estimates, increases or decreases to its warranty liability would be required.  Prior year’s additions to and usage of warranty reserve has been adjusted to conform to the current presentation format.

- 20 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 


8.  
Accumulated Other Comprehensive Income

Accumulated other comprehensive income, net of tax, presented in the accompanying Condensed Consolidated Balance Sheets consists of the accumulated unrealized gains and losses on available-for-sale investments, including the Company’s investments in equity securities, as well as currency translation adjustments relating to local currency denominated subsidiaries and equity investees, and the accumulated unrealized gains and losses related to derivative instruments accounted for under hedge accounting (in thousands).

   
March 29, 2009
   
December 28, 2008
 
Accumulated net unrealized gain (loss) on:
           
Available-for-sale investments
  $ (7,222 )   $ (18,408 )
Foreign currency translation
    42,883       101,186  
Hedging activities
    78,125       106,199  
Total accumulated other comprehensive income
  $ 113,786     $ 188,977  

Comprehensive income (loss) is presented below (in thousands):

   
Three months ended
 
   
March 29, 2009
   
March 30, 2008
 
Net income (loss)
  $ (207,995 )   $ 10,960  
Non-controlling interest
    (494 )      
      (208,489 )     10,960  
Change in accumulated unrealized gain (loss) on:
               
Available-for-sale investments
    11,186       7,793  
Foreign currency translation
    (58,303 )     38,557  
Hedging activities
    (28,074 )     (1,636 )
Comprehensive income (loss)
  $ (283,680 )   $ 55,674  

Non-controlling interest is included in Other Income (Expense) on the Condensed Consolidated Statements of Operations.

The amount of income tax expense allocated to accumulated unrealized gain (loss) on available-for-sale investments and hedging activities was $8.2 million and $7.1 million at March 29, 2009 and December 28, 2008, respectively.

- 21 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 


9.  
Restructuring Plans

In the three months ended March 29, 2009, the Company recorded restructuring expense of $0.8 million, net, related to employee severance costs in Restructuring and Other in the Condensed Consolidated Statements of Operations.


   
Severance and Benefits
 
Restructuring provision
  $ 4.1  
Cash paid
    (3.1 )
Accrual balance at December 28, 2008
    1.0  
Accrual adjustments
    (0.8 )
Accrual balance at March 29, 2009
  $ 0.2  

The remaining restructuring accrual balance is reflected in Other Current Accrued Liabilities in the Condensed Consolidated Balance Sheets and is expected to be utilized in fiscal year 2009.


   
Severance and Benefits
   
Contract Termination Fees and Other Charges
   
Total
 
Restructuring and other provisions
  $ 10.4     $ 21.0     $ 31.4  
Cash paid
    (4.1 )     (2.4 )     (6.5 )
Non-cash utilization
 
      (4.6 )     (4.6 )
Accrual balance at December 28, 2008
    6.3       14.0       20.3  
Restructuring
    1.6    
      1.6  
Cash paid
    (6.2 )     (1.5 )     (7.7 )
Accrual balance at March 29, 2009
  $ 1.7     $ 12.5     $ 14.2  

The Company anticipates that the remaining restructuring accrual balance of $14.2 million will be substantially paid out or utilized in fiscal year 2009.  The remaining restructuring accrual balance is reflected in Other Current Accrued Liabilities in the Condensed Consolidated Balance Sheets.


- 22 -


 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont’d)
 

10.  
Share-Based Compensation

Share-Based Plans.> The Company has a share-based compensation program that provides its Board of Directors with broad discretion in creating equity incentives for employees, officers, non-employee board members and non-employee service providers.  This program includes incentive and non-statutory stock option awards, stock appreciation right awards, restricted stock awards, performance-based cash bonus awards for Section 16 executive officers and an automatic grant program for non-employee board members pursuant to which such individuals will receive option grants or other stock awards at designated intervals over their period of board service.  These awards are granted under various plans, all of which are stockholder approved.  Stock option awards generally vest as follows: 25% of the shares vest on the first anniversary of the vesting commencement date and the remaining 75% vest proportionately each quarter over the next 3 years of continued service.  Restricted stock awards generally vest in equal annual installments over a 2 or 4-year period.  Initial grants under the automatic grant program vest over a 4-year period and subsequent grants vest over a 1-year period in accordance with the specific vesting provisions set forth in that program.  Additionally, the Company has an Employee Stock Purchase Plan (“ESPP”) that allows employees to purchase shares of common stock at 85% of the fair market value at the subscription date or the date of purchase, whichever is lower.


 
Three months ended
 
March 29, 2009